Researchers question WHO guidelines on non-sugar sweeteners, citing a reliance on biased prospective cohort studies over randomized controlled trials. The study calls for an urgent re-evaluation of WHO’s stance, as recent evidence suggests non-sugar sweeteners may actually reduce cardiometabolic risks.
Takeaways from RFK Jr.’s first day before Congress
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
January 30, 2025